{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:10:48Z","timestamp":1760055048796,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.medmal.2005.07.002","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T07:13:45Z","timestamp":1129878825000},"page":"507-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacit\u00e9 et tol\u00e9rance de la clarithromycine, forme \u00e0 lib\u00e9ration modifi\u00e9e en traitement court de cinq jours dans les exacerbations aigu\u00ebs de bronchite chronique, comparativement \u00e0 la t\u00e9lithromycine"],"prefix":"10.1016","volume":"35","author":[{"given":"C.","family":"Perronne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Drugeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Filipecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Vincent-Lacaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"L\u00e9ophonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2005.07.002_bib1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1183\/09031936.02.00042002","article-title":"Chronic bronchitis among French adults: high prevalence and under diagnosis","volume":"20","author":"Huchon","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.medmal.2005.07.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/srin.2000.0150001","article-title":"The role of bacterial infection in chronic bronchitis","volume":"15","author":"Wilson","year":"2000","journal-title":"Semin. Respir. Infect."},{"key":"10.1016\/j.medmal.2005.07.002_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/43.suppl_1.97","article-title":"Infectious exacerbations of chronic bronchitis: diagnosis and management","volume":"43","author":"Sethi","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.medmal.2005.07.002_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/infdis\/145.2.234","article-title":"Prediction of tracheobronchial colonisation in current cigarette smokers with chronic obstructive bronchitis","volume":"145","author":"Irwin","year":"1982","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2005.07.002_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/srin.2000.18077","article-title":"Antibiotic therapy in acute exacerbation of chronic bronchitis","volume":"15","author":"Adams","year":"2000","journal-title":"Semin. Respir. Infect."},{"key":"10.1016\/j.medmal.2005.07.002_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2005.07.002_bib7","first-page":"4S65","article-title":"Actualisation des recommandations pour la prise en charge de la BPCO","volume":"20","year":"2003","journal-title":"Rev. Mal. Respir."},{"article-title":"Antibioth\u00e9rapie par voie g\u00e9n\u00e9rale en pratique courante\u00a0: exacerbation de bronchite chronique","year":"2002","series-title":"Recommandations. Juillet 2001","key":"10.1016\/j.medmal.2005.07.002_bib8"},{"key":"10.1016\/j.medmal.2005.07.002_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0761-8425(04)71284-X","article-title":"Safran C Traitement des exacerbations de bronchopneumopathie chronique obstructive (BPCO) par la pristinamycine","volume":"21","author":"L\u00e9ophonte","year":"2004","journal-title":"Rev. Mal. Respir."},{"key":"10.1016\/j.medmal.2005.07.002_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jac\/44.4.501","article-title":"Five days moxifloxacin therapy compared with 7\u00a0days clarithromicin therapy for the treatment of exacerbations of chronic bronchitis","volume":"44","author":"Wilson","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.medmal.2005.07.002_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0369-8114(01)00269-3","article-title":"\u00c9valuation de l'activit\u00e9 in vitro de la t\u00e9lithromycine sur Haemophilus influenzae","volume":"50","author":"Dabernat","year":"2002","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.medmal.2005.07.002_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0399-077X(03)00021-0","article-title":"\u00c9pid\u00e9miologie de la r\u00e9sistance aux antibiotiques des pathog\u00e8nes respiratoires en France en 2000\u20132001\u00a0; apport de la t\u00e9lithromycine","volume":"33","author":"Drugeon","year":"2003","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.medmal.2005.07.002_bib13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1086\/423959","article-title":"Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease","volume":"39","author":"Van der Valk","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2005.07.002_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0149-2918(01)80031-X","article-title":"Comparison of the efficacy of extended\u2013release clarithromycin tablets and amoxicillin\/clavulanate tablets in the treatment of acute exacerbations of chronic bronchitis","volume":"23","author":"Anzueto","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.medmal.2005.07.002_bib15","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/rmed.2002.1382","article-title":"Telithromycin is as effective as amoxycillin\/clavulanate in acute exacerbation of chronic bronchitis","volume":"96","author":"Aubier","year":"2002","journal-title":"Resp. Med."},{"key":"10.1016\/j.medmal.2005.07.002_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/147323000303100301","article-title":"Oral telithromycin 800\u00a0mg once daily for five days vs cefuroxime axetil 500\u00a0mg twice daily in adults with exacerbations of chronic bronchitis","volume":"31","author":"Zervos","year":"2003","journal-title":"J. Internat. Med. Res."},{"issue":"2","key":"10.1016\/j.medmal.2005.07.002_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1185\/030079905X26243","article-title":"Comparative efficacy of once daily, 5\u00a0days short-course therapy with clarithromycin extended-release versus twice daily, 7\u00a0days therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis","volume":"21","author":"Gotfried","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.medmal.2005.07.002_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0149-2918(01)80033-3","article-title":"Comparison of 5\u00a0days, short-course gatifloxacin therapy with 7\u00a0days gatifloxacin therapy and 10\u00a0days clarithromycin therapy for acute exacerbation of chronic bronchitis","volume":"23","author":"Gotfried","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.medmal.2005.07.002_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/rmed.1999.0708","article-title":"Aneiro L and the bronchitis study group. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis","volume":"94","author":"Chodosh","year":"2000","journal-title":"Resp. Med."},{"key":"10.1016\/j.medmal.2005.07.002_bib20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0149-2918(02)80045-5","article-title":"Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbation of chronic bronchitis","volume":"24","author":"Weiss","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.medmal.2005.07.002_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00044011-199917010-00003","article-title":"Efficacy and tolerability of once-daily grepafloxacin compared with clarithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis","volume":"17","author":"DeAbate","year":"1999","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.medmal.2005.07.002_bib22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/S0149-2918(00)83040-4","article-title":"Phase III, randomized, double blind study of clarithromycin extended release and immediat- release formulation in the treatment of patients with acute exacerbation of chronic bronchitis","volume":"12","author":"Adler","year":"2000","journal-title":"Clin. Ther."},{"key":"10.1016\/j.medmal.2005.07.002_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1185\/030079903125002018","article-title":"Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double blind, randomized, multicenter comparison of extended release versus immediate release clarithromycin","volume":"19","author":"Napela","year":"2003","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.medmal.2005.07.002_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2004.03.003","article-title":"Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance","volume":"24","author":"Anzueto","year":"2004","journal-title":"Internat. J. Antimicrob. Ag."},{"key":"10.1016\/j.medmal.2005.07.002_bib25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0149-2918(01)80060-6","article-title":"Pharmacokinetics and tolerability of extended-release clarithromycin","volume":"23","author":"Guay","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.medmal.2005.07.002_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03256648","article-title":"Clarithromycin extended release tablet. A review of its use in management of respiratory tract infections","volume":"32","author":"Darkes","year":"2003","journal-title":"Am. J. Respir. Med."},{"key":"10.1016\/j.medmal.2005.07.002_bib27","unstructured":"Devcich K, Olson C, Shortridge D, Notario G. Clarithromycin has maintained efficacy and potency in an era of increased macrolide-resistant Streptococcus pneumoniae. Presented at the 6th European Congress of Chemotherapy and Infection (ECC), December 1\u20133, 2004."}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X05001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X05001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:53:01Z","timestamp":1759971181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X05001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0399077X05001794"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2005.07.002","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacit\u00e9 et tol\u00e9rance de la clarithromycine, forme \u00e0 lib\u00e9ration modifi\u00e9e en traitement court de cinq jours dans les exacerbations aigu\u00ebs de bronchite chronique, comparativement \u00e0 la t\u00e9lithromycine","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2005.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}